The turning point in her life was reached, quite surprisingly, at a party with friends in 2016. As Milana tells it, “They knew I worked in the pharmaceutical industry, and a friend at the party approached me and begged, ‘Can’t you develop something to help my psoriasis? You know, I’ve been suffering for years, not going to the pool with my wife and kids, not enjoying life, being the object of endless looks and questions ‘Is it contagious?’ and suffering from the unbearable itch and pain which prevents me from sleeping at night. I’ve tried everything!’”

Her friend’s plea kept her up at night. “I was looking for a solution, a new outside the-box approach, a groundbreaking insight which led me to the study of the dermal microbiome , or skin probiotics for short.

“More precisely, my research found that the bacterial population on the skin of psoriasis sufferers, differs from the population found on healthy skin. Specifically, one important family of bacteria is missing. I found a safe bacterium from that family, already in commercial use in the food industry that can help restore the skin’s healthy dermal microbiome and we developed it into a topical, oil based suspension formulation. After proving the safety of the new formulation, we were able to register the product as a cosmetic.

“There are trillions of bacteria in the world and it could take centuries to find the right one, which is effective and safe – a unique combination. Throughout my extensive research I felt that I was being guided through divine intervention. Out of hundreds of articles – I read the right ones. Out of thousands of possible formulations – I found the right one. I am so thankful to G-d that brought me this opportunity to help people.”

In January 2018, Ms. Anash founded ClearSkin Ltd., the company that developed and commercially manufactures MiBiomeTM, containing those good bacteria (skin probiotics) and improves the skin quality and well-being of people suffering from conditions like psoriasis, atopic dermatitis, red and irritated skin, pruritis and more. The company registered a patent on this novel invention, and received funding from the Israeli Innovation Authority in recognition of the novelty, creativity and innovation that this advance represents.

The success of MiBiomeTM has brought it to prominence in the scientific and medical arenas. Milana has attended and spoken before conferences in Israel, Europe and the USA, where she has lectured on the relevance of the skin microbiome and probiotics in the field of dermatological cosmetics.

Ms. Anash and the product she developed have been widely acclaimed by patients and physicians alike. MiBiomeTM has been commercially available in pharmacies and natural products outlets in Israel since mid-2018, reaching more patients every month. MiBiomeTM was launched internationally in 2019 and is making excellent progress in global markets.